Tag: Inflection Point Ventures

• Iom Bioworks is dedicated to using the gut microbiome’s power to revolutionize contemporary healthcare.
• The funds will be used to boost customer outreach, secure IP rights, scale infrastructure, and grow the core team.
• In its first year, Iom Bioworks reached 500 users, secured two patents globally (with two more underway), and published multiple papers in the microbiome and computational biology space.
• So far, Inflection Point Ventures has invested over INR 800 Cr across 210+ startups.

Iom Bioworks, a deep science company pioneering microbiome-focused healthcare, has secured INR 4 crore in seed round funding led by Inflection Point Ventures (IPV). The capital will be leveraged for marketing, securing intellectual property claims, strengthening core infrastructure and scaling scientific and commercial teams.

Founded in 2022, Iom Bioworks personalises health by identifying key bacteria in the gut and modulating them in a targeted manner for enhanced, improved overall health and well-being. Their patented platform combines large-scale knowledge graphs mined through Artificial Intelligence (AI)  and advanced modelling techniques that ensure Iom achieves precise and personalised recommendations for its users.

Iom Bioworks reached more than 500 customers in just the first year and has 2 patents granted and 2 in advanced stages. They have key scientific publications in leading scientific journals. Iom Bioworks have Pan India logistics and has established digital access for personalised microbiome services.

Bipin Pradeep Kumar, Co-Founder and CEO, brings a strategic vision and collaborative approach to leadership, integrating microbiome research with technology, artificial intelligence and customer focus. Dr. Samik Ghosh, Co-Founder & Chief of Science & Technology, uses his expertise at the intersection of computation and biology to develop innovative microbiome-driven health and wellness solutions that drive sustainable health for life of people and the planet. Dr. Hiroaki Kitano, Co-Founder & Chief of Research & Collaboration, a world-renowned systems biologist and AI specialist, brings decades of leadership in robotics, systems biology, and AI-driven scientific discovery to create innovative collaborations.

“Lifestyle diseases have been on the rise due to multiple reasons like poor diet, stress, lack of sleep and are intimately linked to poor gut health and microbial composition. The gut microbiome plays a huge role in your digestion, immunity, metabolism, and even mood. Understanding it can help prevent a myriad of these diseases and also provide a better quality of life. Iom Bioworks is making this cutting-edge science accessible, personalised and importantly, actionable. With their vision and science, they make a compelling bet in preventive and therapeutic healthcare”, says Vinay Bansal, Founder, IPV. 

“Iom Bioworks envisions a world where a healthy mind and body are achievable through informed choices that nurture the microbiome. By empowering our inner ecosystem through prebiotics and a food and lifestyle centred around the bacteria, we aim to energize daily life while preserving the joy of living. Partnering with IPV has been transformative; their supportive and diligent approach has set us firmly on the path toward this vision”, says Bipin Pradeep Kumar.

At a compound annual growth rate (CAGR) of 28%, the worldwide market for health tests, subscriptions, and wellness platforms is expected to reach USD 900 billion by 2030. Iom Bioworks is well positioned to lead this transformation to personalised, accessible gut health with its scalable approach, user focus and the foundation of deep science and research. 

About Iom Bioworks

Iom Bioworks is a Bengaluru-based deep science company advancing health through identifying and therapeutically modulating key bacteria to improve well-being. Combining cutting-edge biological network theory, mathematical modelling, and nutritional science with the power of AI, the company provides personalised food and prebiotic recommendations.

These individualised microbiome solutions are offered to customers throughout India with at-home gut profiling kits and an end-to-end digital experience. Founded in 2022, Iom Bioworks is led by a team of global experts across biology, AI, and systems health.

About Inflection Point Ventures and Physis Capital

Inflection Point Ventures (IPV) is an angel investing platform with over 23,500+ CXOs, HNIs, and Professionals to together invest in startups. The firm supports new-age entrepreneurs by providing them with monetary & experiential capital and connecting them with a diverse group of investors. IPV has launched a $50 Mn CAT 2 VC fund, Physis Capital, to invest in Pre-Series A to Series B growth-stage start-ups. The fund has already deployed capital in two startups so far, with a few deals in advanced stages of the pipeline.

Ziniosa Raises Funding from IPV to Lead Fashion Resale

Ziniosa is India’s leading platform for buying and selling authenticated preloved luxury fashion. Ziniosa is the exclusive preloved fashion partner on Tata Cliq Luxury with an 80% sell-through rate.

StartupTalkyStartupTalky News

• Major exits include Prescinto AI’s acquisition by IBM and Parablu’s sale to CrashPlan, showcasing the attractiveness of IPV-backed startups.
• IPV portfolio companies raised 25 follow-on rounds in 2024, attracting top-tier investors and providing 30-40% IRRs through optional exits.
• IPV has achieved 47 exits out of a 200+ startup portfolio over the last five years, a significantly higher exit rate compared to industry norms.

Inflection Point Ventures, the most active angel network in India, announces 14 exits from 2024, delivering an IRR of ~36% and reinforcing its ability to generate liquidity for its investors. With 47 successful exits from a portfolio of 200+ startups, IPV has delivered exit opportunities at a rate well above industry norms, reinforcing its strong track record in venture investing.

“Our focus has always been on identifying and supporting businesses with the potential to scale and deliver strong returns,” said Vinay Bansal, Founder & CEO of IPV. “Despite the market slowdown, our ability to deliver consistent exits reflects the strength of our portfolio and the trust we’ve built with both investors and founders.”

IPV has successfully facilitated multiple high-return exits, demonstrating its expertise in identifying scalable businesses. Among them, Aksum (52% IRR, 1.55x MoM), Conscious Chemist (54% IRR, 1.45x MoM), and Qubehealth (53% IRR, 4.06x MoM) delivered significant investor returns. These exits, along with several others, reinforce IPV’s strategy of backing high-potential startups that create meaningful investor value.

While the funding winter persisted, IPV portfolio companies secured 25 follow-on rounds, an achievement that stands out in a challenging market. These rounds were led by renowned global and domestic investors, reinforcing strong conviction in IPV-backed startups and their growth potential.

This continued investor confidence is evident in the backing IPV startups have received from top-tier funds. Goodwater Capital invested in Stage, alongside Blume Ventures, which also backed Fashor. Kazam attracted funding from Vertex Ventures, Avaana, and Chakra, while Sorin and Piper Serica supported Freed. DS Group’s investment in Samosa Party further highlights the trust established investors place in IPV’s portfolio. Adding to this momentum, Tim Draper’s investment in BonV Aero reinforces IPV’s rigorous due diligence, showcasing the confidence of globally recognized investors in IPV-backed startups.

Another major highlight of the year was the appearance and funding of two IPV-backed startups—Speed Kitchen and Metashot—on Shark Tank Indiathat , further underscoring the visibility and credibility of IPV startups in the larger ecosystem.

Some of these strategic investments were structured as blended primary and secondary transactions, providing optional exits to IPV investors, delivering 30-40% IRRs with a 3- 4x return.

“The ability of our startups to attract follow-on funding from top-tier VCs and corporates underscores the quality of companies we back,” said Ankur Mittal, Co-founder of IPV. “By consistently identifying high-growth potential and fostering strategic relationships, we ensure that our investors benefit from both capital appreciation and early liquidity.”

Beyond securing fresh capital, IPV-backed companies have also proven to be attractive targets for acquisitions and strategic collaborations, validating their strong technology and market potential. Prescinto AI, an AI-powered platform optimizing renewable energy assets, was acquired by IBM, integrating its technology into IBM’s Maximo Application Suite to enhance the energy sector’s efficiency and sustainability. This exit delivered a 28% IRR with a 2.17x return. Similarly, Parablu, a data protection company, was acquired by CrashPlan, a global leader in cyber-ready data resilience. The acquisition not only integrated Parablu’s solutions but also onboarded its team, ensuring a smooth transition and continued business growth. This exit generated an IRR of ~30% with a 2.2x MoM in 36 months.

“Our focus goes beyond just funding—we actively support our startups in scaling and securing strategic exits,” said Mitesh Shah, Co-founder of IPV. “By enabling them to attract the right investors and acquirers, we ensure liquidity opportunities for our investors, even in challenging market cycles.”

A report by the Indian Venture and Alternate Capital Association (IVCA) and EY highlights that only 10-15% of startups in India provide successful exits to investors. IPV has consistently exceeded market trends, with more than half of its portfolio businesses already obtaining exits or follow-on investment. This impressive track record demonstrates IPV’s ability to handle market obstacles and generate meaningful results for its investor community.

About Inflection Point Ventures and Physis Capital

Inflection Point Ventures (IPV) is an angel investing platform with over 23,500+ CXOs, HNIs, and Professionals investing together in startups. The firm supports new-age entrepreneurs by providing them with monetary & experiential capital and connecting them with a diverse group of investors.IPV has launched a $50 Mn CAT 2 VC fund, Physis Capital, to invest in Pre-Series A to Series B growth-stage startups. The fund has already deployed capital in two startups so far, with a few deals in advanced stages of the pipeline.

Top 5 Startup Investing Platforms in India

Are you an Angel Investor planning to invest in Startups or an entrepreneur planning to raise funds, know the top 5 Startup Investing platforms.

StartupTalkyMuskaan Kapoor